Bumper Offer - Urjas oil Just @ Rs. 1
Celtranz, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Bleeding. Celtranz also has some secondary and off-label uses. These are listed below.
The right dosage of Celtranz depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Celtranz can also lead to other problems, which have been listed below. Usually, these side effects of Celtranz go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Celtranz is Moderate for pregnant women and Safe for women who are breastfeeding. In addition, Celtranz's effects on the liver, heart and kidney are discussed below in the Celtranz related warnings section.
Celtranz is contraindicated in people with pre-existing medical conditions like Blood Cancer, Colour Blindness, Allergy as it can result in adverse effects.
Drug reaction of Celtranz with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Celtranz is considered safe while driving, and is addictive.
Celtranz is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Celtranz is used -
Severe
Moderate
Mild
Is the use of Celtranz safe for pregnant women?
Celtranz may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Celtranz again without your doctor's advice.
Is the use of Celtranz safe during breastfeeding?
Celtranz is completely safe for breastfeeding women.
What is the effect of Celtranz on the Kidneys?
Celtranz can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Celtranz on the Liver?
Side effects of Celtranz rarely affect the liver.
What is the effect of Celtranz on the Heart?
The heart can be affected by Celtranz. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Celtranz should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Celtranz unless your doctor advises you to do so -
Is this Celtranz habit forming or addictive?
Forming a habit of Celtranz has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Celtranz does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Celtranz should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Celtranz in mental disorders is not effective.
Interaction between Food and Celtranz
Information is not available on the interaction of any foods with Celtranz, due to a lack of research on this.
Interaction between Alcohol and Celtranz
Information about the interaction of Celtranz and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 628-629
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lysteda™ (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyklokapron® (tranexamic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 628-629
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lysteda™ (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyklokapron® (tranexamic acid)
